Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FMJ7G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,988
Award facts
- Contract value 100% obligated
- $41,988.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,988.02 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of December 31, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries with DLA and other federal healthcare entities, including the Defense Health Agency and U.S. Coast Guard. Trelegy Ellipta is a combination respiratory medication used for chronic obstructive pulmonary disease management, reflecting AmerisourceBergen's role in supplying specialty medications and brand-name pharmaceuticals across multiple therapeutic domains to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FMJ7G?
SPE2DR26FMJ7G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FMJ7G worth?
The government has obligated $41,988 on SPE2DR26FMJ7G.
Is contract SPE2DR26FMJ7G an order under another contract?
Yes. SPE2DR26FMJ7G is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMJ7G competed?
The extent of competition for SPE2DR26FMJ7G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award